Balyasny Asset Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Balyasny Asset Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-225,005	Closed	-$2.28M	–	3400
2022 Q3	$2.28M	Buy	225,005 +25,005	+13%	+$252K	0.01%	1432
2022 Q2	$2.01M	Hold	200,000	–	–	0.01%	1391
2022 Q1	$2M	Hold	200,000	–	–	0.01%	1343
2021 Q4	$2M	Buy	+200,000	New	+$1.98M	0.01%	1214

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Balyasny Asset Management's ARCK Position: Q4 2022 in Review

Balyasny Asset Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 225,005 shares — an estimated $2.28M sold.

Balyasny Asset Management first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $2.28M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Balyasny Asset Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Balyasny Asset Management sold 225,005 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $2.28M.
Balyasny Asset Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Balyasny Asset Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $2.28M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.